Shanghai, China · Founded 2013 · Privately Held (backing)
Developer of hypertension interventional devices designed for medical health. Brattea is based in Shanghai, China and was founded in 2013. Its last reported valuation was $422 million in Feb 2025. It has raised $144 million.
Last reported valuation
$422.3M
Oct 2026
Priced at
—
Total raised
$144.3M
Last round
—
Cap table — not yet on record
Brattea's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Brattea with a free account
·The complete investor list: 20 names
·Watch Brattea: the Monday email on marks, rounds and moves
